Page last updated: 2024-10-30

leflunomide and Aortitis

leflunomide has been researched along with Aortitis in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Aortitis: Inflammation of the wall of the AORTA.

Research Excerpts

ExcerptRelevanceReference
" Results of in-vitro studies on Janus kinase (JAK)/signal transducers and activators of transcription and mammalian target of rapamycin (mTOR) pathways, comparative studies with leflunomide as an induction therapy, and a long-term follow-up study with tocilizumab may contribute to the management of Takayasu arteritis."5.12Aortitis: an update. ( Erdogan, M, 2021)
"Noninfectious aortitis has been increasingly reported worldwide with a growing prevalence in western medicine."1.56Noninfectious aortitis: A case report. ( Hingorani, A; Jaikaran, O; Nicoara, M, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Jaikaran, O1
Nicoara, M1
Hingorani, A1
Erdogan, M1

Reviews

1 review available for leflunomide and Aortitis

ArticleYear
Aortitis: an update.
    Current opinion in rheumatology, 2021, Volume: 33, Issue:1

    Topics: Antibodies, Monoclonal, Humanized; Aorta; Aortitis; Female; Follow-Up Studies; Giant Cell Arteritis;

2021

Other Studies

1 other study available for leflunomide and Aortitis

ArticleYear
Noninfectious aortitis: A case report.
    Vascular, 2020, Volume: 28, Issue:5

    Topics: Abdominal Pain; Aged; Aortitis; Back Pain; Glucocorticoids; Humans; Immunosuppressive Agents; Leflun

2020